John A. Lewicki Mereo Biopharma Group PLC (MREO) insider trading activity
John A. Lewicki is Chief Scientific Officer of Mereo Biopharma Group plc. Currently has a direct ownership of 78,630 shares of MREO, which is worth approximately $310,588. The most recent transaction as insider was on Sep 13, 2024, when has been sold 10,937 shares (American Depositary Shares representing Ordinary Shares) at a price of $4.22 per share, resulting in proceeds of $46,154. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
78.6K
n/a
3M change
n/a
12M change
Total Value Held
$310,588
John A. Lewicki Transaction History
JAL
John A. Lewicki
Chief Scientific Officer
London, X0